Squarepoint
CVS icon

Squarepoint’s CVS Health CVS Stock Holding History

Squarepoint’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$488K Sell
6,800
-99,000
-94% -$7.63M ﹤0.01% 3351
2025
Q4 		$8.4M Sell
105,800
-13,800
-12% -$1.09M 0.01% 1162
2025
Q3 		$9.02M Sell
119,600
-163,000
-58% -$11.2M 0.01% 1131
2025
Q2 		$19.5M Sell
282,600
-1,071,900
-79% -$70.3M 0.02% 778
2025
Q1 		$91.8M Buy
1,354,500
+594,100
+78% +$35.6M 0.11% 176
2024
Q4 		$34.1M Sell
760,400
-78,900
-9% -$4.43M 0.03% 512
2024
Q3 		$52.8M Buy
839,300
+362,200
+76% +$21.1M 0.08% 225
2024
Q2 		$28.2M Buy
477,100
+74,700
+19% +$4.67M 0.05% 434
2024
Q1 		$32.1M Buy
402,400
+231,300
+135% +$17.7M 0.06% 412
2023
Q4 		$13.5M Buy
171,100
+116,800
+215% +$8.31M 0.03% 770
2023
Q3 		$3.79M Sell
54,300
-102,500
-65% -$7.26M 0.01% 1360
2023
Q2 		$10.8M Sell
156,800
-22,100
-12% -$1.57M 0.03% 622
2023
Q1 		$13.3M Buy
178,900
+138,600
+344% +$11.6M 0.05% 434
2022
Q4 		$3.76M Buy
+40,300
New +$3.89M 0.01% 978
2022
Q2 		– Sell
-168,200
Closed -$17M – 2960
2022
Q1 		$17M Buy
168,200
+23,000
+16% +$2.42M 0.07% 287
2021
Q4 		$15M Buy
145,200
+13,100
+10% +$1.21M 0.04% 391
2021
Q3 		$11.2M Buy
132,100
+103,200
+357% +$8.64M 0.03% 460
2021
Q2 		$2.41M Sell
28,900
-58,100
-67% -$4.76M 0.01% 1082
2021
Q1 		$6.54M Sell
87,000
-2,600
-3% -$189K 0.04% 519
2020
Q4 		$6.12M Buy
+89,600
New +$5.83M 0.05% 403
2019
Q4 		– Sell
-5,700
Closed -$359K – 2528
2019
Q3 		$359K Buy
+5,700
New +$338K ﹤0.01% 1799

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Squarepoint's CVS Position: Q1 2026 in Review

Squarepoint increased its CVS Health (CVS) stake by 1,238% in Q1 2026, buying an estimated $32.3M and bringing the position to 452,564 shares worth $32.5M. The position accounts for 0.04% of the portfolio, ranked #482.

Squarepoint first reported a position in CVS in Q4 2014 and has held it in 41 quarters since. The position peaked at $156M in Q1 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Squarepoint held 452,564 shares of CVS Health worth $32.5M as of Q1 2026.
  • Squarepoint bought 418,734 CVS Health shares in Q1 2026, an estimated $32.3M.
  • CVS Health made up 0.04% of Squarepoint's portfolio in Q1 2026, its #482 holding.
  • Squarepoint first reported a position in CVS Health in Q4 2014 and has held it in 41 quarters since.
  • Squarepoint's CVS Health position peaked at $156M in Q1 2023.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.